Page last updated: 2024-11-06

demegestone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Demegestone is a selective progesterone receptor modulator (SPRM) that has shown promise in treating a variety of conditions, including endometriosis, uterine fibroids, and hormone-dependent cancers. It is a synthetic steroid that acts as a partial agonist of the progesterone receptor, meaning it binds to the receptor but does not activate it to the same extent as natural progesterone. Demegestone is currently undergoing clinical trials to evaluate its efficacy and safety in these conditions. Its importance lies in its potential to provide a safer and more effective treatment option compared to existing therapies, with fewer side effects.'

demegestone: a norprogesterone derivative that acts like PROGESTERONE in increasing SEX HORMONE-BINDING GLOBULIN; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93057
CHEMBL ID2104231
CHEBI ID135339
SCHEMBL ID146550
MeSH IDM0057329

Synonyms (31)

Synonym
D07223
demegestone (inn)
demegestone
r 2453
10116-22-0
nsc-118189
CHEBI:135339
(8s,13s,14s,17s)-17-acetyl-13,17-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
einecs 233-320-6
6e89am91sz ,
demegestonum
nsc 118189
demegestona [inn-spanish]
unii-6e89am91sz
17alpha-methyl-19-demethylpregna-4,9-diene-3,20-dione
demegestona
17-methyl-19-norpregna-4,9-diene-3,20-dione
demegestone [inn:dcf]
19-norpregna-4,9-diene-3,20-dione, 17-methyl-
demegestonum [inn-latin]
r-2453
CHEMBL2104231
demegestone [mi]
demegestone [inn]
demegestone [who-dd]
demegestone [mart.]
SCHEMBL146550
DTXSID20878581
DB13857
Q5255131
AKOS040746746
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
20-oxo steroidAn oxo steroid carrying an oxo group at position 20.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1150123Relative binding affinity to rabbit progesterone receptor1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (20.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]